CEO Cancer Diagnostics – General Board / NED – Biotechnology – Ref.: JVM010617O
Our client has a suite of tests in cancer diagnostics and the 1st product is now CE marked and ready for launch.
The successful candidate will be responsible for developing the business plan and the “go to market strategy” in line with board and investor expectations to critically establish the company as a leading player in the oncology biomarker diagnostic market internationally. The role holder will be responsible for ensuring that the business operations are run in accordance with legal and regulatory standards and will represent the business on the global stage with ongoing dialogue with key opinion leaders, cancer patient groups, relevant charities, industry leaders, healthcare payers and other stakeholders.
The role will suit a driven, entrepreneurial and proven Chief Executive Officer who has a track record of successfully building commercial value from biomarker or other diagnostic technology across multiple markets and ideally have experience of both the private and reimbursement payers.